Abstract
Significant atrophic gastritis in the fundic gland region is a well-known endoscopic finding observed in autoimmune gastritis (AIG). The endoscopic features of early AIG have not been reported. Iron deficiency, vitamin B12 deficiency, anemia, or neurological symptoms may not be observed in the early stages of AIG, and it may thus be difficult to diagnose early AIG based on clinical findings. We treated a 50-year-old Japanese female whose condition was suspected to be early AIG. The endoscopic findings showed normal gastric pyloric gland mucosa, and diffuse reddened and edematous gastric fundic gland mucosa. Pathologically, local infiltration of lymphocytes and decrease of parietal cells was present in a deep part of the gastric fundic gland mucosa. Blood tests showed that the titer of parietal cell antibody (PCA) was 1:320 and the gastrin level was 820 pg/ml. We determined that the patient had AIG because she also had Hashimoto’s disease, the PCA titer was high, the serum gastrin level was slightly increased, and inflammation was observed only in the gastric body on the endoscopic images. To the best of our knowledge, this is the first case report of endoscopic findings that suggest early AIG, before atrophic changes were observed.
Keywords: Autoimmune gastritis, Type A gastritis, Hashimoto’s disease
Introduction
Endoscopic findings are important as a clue to the diagnosis of autoimmune gastritis (AIG). A typical endoscopic finding of AIG is the presentation of significant and severe atrophic gastritis in the fundic gland region, which is also known in Japan as “endoscopic reversed type atrophic gastritis” as reported by Kurokawa et al. [1]. Since the report on Type A gastritis by Strickland et al. was published in 1973, it has been known that an autoimmune-positive result, iron deficiency anemia, pernicious anemia, and hypergastrinemia are observed in typical AIG [2]. AIG was thought to be a rare disease in Japan, but the recent awareness of AIG in Japan has increased, as has the AIG detection rate; this has led to an increased number of reports on AIG [3]. However, there are no reports on the endoscopic features of early AIG, in part because clinical laboratory test results may not be significantly abnormal in the early stages of AIG. Herein, we report the case of our patient who we diagnosed as having early AIG based on endoscopic findings, laboratory findings, and histopathological findings.
Case report
The patient was a 50-year-old Japanese woman. She had never received eradication therapy for Helicobacter pylori (H. pylori). She had not used any medications for the treatment of a peptic ulcer such as proton pump inhibitors, or H2-receptor antagonists; nor had she taken any digestive enzyme drugs, non-steroidal anti-inflammatory drugs, or antithrombotic drugs.
She visited our hospital for a detailed examination because abnormal findings had been detected by endoscopy when she underwent a medical check-up. The detected findings in a medical check-up were the diffuse reddened changes in the gastric fundic gland mucosa. She had no symptoms. The results of blood tests performed at the time of her first visit are shown in Table 1. The test result for the presence of the H. pylori antibody was negative, and that for thyroid peroxidase (TPO) antibody was positive due to the patient’s Hashimoto’s disease.
Table 1.
Hematology | ||
White blood cell | 4090 | /µL |
Red blood cell | 4.47 | × 106/µL |
Mean corpuscular volume | 90.6 | fl |
Mean corpuscular Hemoglobin | 30.2 | pg |
Hemoglobin | 13.5 | g/dl |
Hematcrit | 40.5 | % |
Platelet | 16.4 | × 104/µL |
Biochemistry | ||
Total protein | 7 | g/dl |
Total bilirubin | 0.7 | mg/dl |
Aspartate Aminotransferase | 20 | U/L |
Alanine aminotransferase | 14 | U/L |
Lactate dehydrogenase | 185 | U/L |
Blood urea nitrogen | 15.5 | mg/dl |
Creatinine | 0.71 | mg/dl |
Na | 143 | mEq/L |
K | 4.1 | mEq/L |
Cl | 106 | mEq/L |
Serology | ||
Thyroid stimulating Hormone | 2.22 | µU/ml |
Free triiodothyronine | 2.86 | pg/ml |
Free thyroxine | 1.44 | pg/ml |
Thyroid peroxidase antibody | 96 | U/ml |
The endoscopy performed at our hospital revealed reddend and edematous change of the gastric areas extensively in the gastric fundic gland mucosa by conventional white-light imaging (Fig. 1), and not revealed significant atrophic images. As a result of strong extension due to insufflation of a large amount of air during the examination, reddened and edematous change of the gastric areas were observed a mixed finding of the small red ridge and the depressed pale areas. We then observed the microanatomy of the gastric areas by magnifying endoscopy with narrow-band imaging (ME-NBI). The microvascular architecture of the fundic gland mucosa had a regular honeycomb-like subepithelial capillary network (SECN) pattern with collecting venules, and the microsurface pattern showed a regular oval crypt opening and normal marginal crypt epithelium (MCE). These microvascular and microsurface patterns, which were morphologically described in normal fundic gland mucosa by Yao et al. (2008), were well-preserved [4]. Nevertheless, both the SECN and the collecting venules become gradually dilated toward the central part of slightly elevated gastric areas (Fig. 2).
No abnormalities in the gastric pyloric gland were observed by conventional endoscopy. In addition, a regular coil-shaped SECN pattern and a regular curved MCE pattern were observed by ME-NBI. Thus, all endoscopic findings showed that the gastric pyloric gland mucosa was normal (Fig. 3).
The histopathological findings of biopsy specimens are shown in Fig. 3. The findings obtained from the pyloric glands region did not show atrophy and intestinal metaplasia. Immunostaining with gastrin showed mild hyperplasia of G-cells. The histopathological findings of a biopsy specimen obtained from the greater curvature in the middle part of the gastric corpus did not show atrophy, intestinal metaplasia, eosinophilic infiltration, noncaseating granulomas, inclusion bodies suggesting viral infection, or decreased parietal cells but did demonstrate a dense lymphocyte infiltration without neutrophils in the middle-to-deep part of the lamina propria mucosa. And immunostaining for H+/K+-ATPase and Pepsinogen I in this specimen were negative in the area with a dense lymphocyte infiltration.
Although no definitive gastric atrophy was identified on the endoscopic and histopathological findings, we made the diagnosis of early AIG based on the following findings. (1) A diffuse inflammatory change was clearly present in the endoscopic findings limited to the fundic gland part without H. pylori infection. (2) Dense lymphocyte infiltration with parietal cell damage was present in the middle-to-deeper part of the lamina propria mucosa in the histopathological findings. (3) The patient had a history of Hashimoto’s disease. In the laboratory examination added after the endoscopy (Table 2), (4) the titer of parietal cell antibody (PCA) was increased to 1:320. (5) Although iron deficiency, vitamin B12 deficiency, and a decreased pepsinogen I level were not observed, the gastrin level was high. And no gastrin-producing tumor was found on CT examination. The patient's endoscopic findings might be thus characteristic of AIG at its early stage.
Table 2.
Serology | ||
H. pylori IgG | < 3 | U/ml |
Parietal cell antibody | 320 | |
Intrinsic factor antibody | – | |
Gastrin | 820 | pg/ml |
Pepsinogen I | 72.7 | ng/ml |
Pepsinogen II | 17.7 | ng/ml |
Pepsinogen I/II | 4.1 | |
Biochemistry | ||
Fe | 124 | µg/ml |
Vitamin B12 | 437 | pg/ml |
An year later, the second endoscopy was performed. No significant changes in the gastric fundic gland mucosa and blood tests showed no significant changes in the AIG marker. At the time of the examination, biopsy was performed separately for the small red ridge and the depressed pale area. As a result, the area of lymphocyte infiltration accompanied by parietal cell damage was predominantly present in the pale area (Fig. 4).
Discussion
AIG has been reported by Strickland and Mackay as a chronic inflammatory disease that yields positive test results for PCA or intrinsic factor antibody, gastric corpus atrophy, gastric acid hyposecretion, and hypergastrinemia [2]. Endoscopists are aware that “reverse atrophy” is a typical endoscopic feature of AIG. In term of ME-NBI findings, Yagi et al. reported that closely arranged small round and oval pits were observed in the atrophic mucosa of AIG [5]. Our patient showed no typical endoscopic findings of AIG. ME-NBI findings also differed from the previously reported by Yagi et al. regarding such endoscopic findings of AIG, the distribution of mucosal inflammatory changes in our patient was the same as that of typical AIG cases, but the detailed endoscopic findings were different. Namely, there was no atrophic change in the gastric fundic gland mucosa; instead, we observed diffuse reddened mucosa and edematous change in the gastric area. When we examined these findings using ME-NBI, it was apparent that both the microvascular pattern and the microsurface pattern in the normal gastric fundic mucosa were well-preserved. Accordingly, we speculated that the reddened mucosa and edematous change were not due to inflammation of the mucosal surface epithelium but rather were due to inflammation in the lamina propria mucosa at a greater depth than the subepithelial part.
In fact, the histopathological findings of the biopsied specimen obtained from the patient’s inflamed mucosa demonstrated that chronic inflammatory cells with parietal cell damage were more densely infiltrated in the middle-to-deep part of the lamina propria mucosa compared to the superficial part. We speculated that the endoscopic findings of reddened mucosa and edema would progress to the typical appearance of atrophic mucosa when the parietal cells were extensively damaged after the inflammation persisted. We thus considered this patient’s endoscopic findings characteristic of the early stage of AIG that had not yet progressed to atrophic gastritis. There has been no prior report of similar endoscopic findings, to the best of our knowledge.
Currently, a definitive diagnosis of AIG is generally made by comprehensive judgment based on endoscopic findings, blood test findings, and histopathological findings. Evidence and data regarding early AIG have been very limited, and this contributes to the significant difficulty in diagnosing early AIG. Torbenson et al. described histopathological features of AIG at an earlier stage, before the parietal cells were completely destroyed [6]. As one of the features, they described damage to fundic glands due to local and diffuse lymphocyte infiltration. In our patient, the damage that we observed in the middle-to-deep part of the fundic gland mucosa is similar to this described feature of early AIG.
We suspected that our patient had parietal cell impairment, which prevents the secretion of gastric acid, because (1) the test result for PCA was positive, (2) hypergastrinemia was observed, (3) mild G-cell hyperplasia in the pyloric gland tissue was observed, and (4) enlarged gastric areas were diffusely observed in the fundic gland region. Although these findings suggested hyposecretion of gastric acid, we did not perform the direct measuring method such as 24-h gastric pH monitoring and could not prove it by serum pepsinogen value alone which is the indirect method. These were the limitation of this report. However, the severity of her parietal cell damage was milder than that observed in typical AIG; and, the fundic glands were well-preserved. Anemia, iron deficiency, and vitamin B12 deficiency were not observed. Samloff et al. had already reported on the comparison of PG values in cases classified by histological findings of the gastric mucosa [7]. According to that report, both PG1 and PG2 increased in the "superficial gastritis group", and PG1 decreased in the "atrophic gastritis group" compared with the "normal group" without inflammation and atrophy. Both values of PG1 and PG2 in our case showed an increase.
Accordingly, we speculated that the fundic gland mucosa in this case might be in the pre-stage of the atrophy. In other words, we thus suggested that the stage of AIG in this patient was not at an advanced stage.
Tozzoli et al. reported that in AIG, the titer of PCA decreased over time along with a reduction in parietal cells, which are the target antigens of PCA [8]. We therefore inferred that such a reduction in parietal cells is caused by persistent inflammation, disease progression, and the decreased PCA titer. Given these findings, we determined that the patient, in whom the titer of the antibody was high and the parietal cells were pathologically not reduced, had early AIG.
In conclusion, our patient’s endoscopic findings of diffuse reddened and edematous change in the gastric fundic gland mucosa and the histological findings of focal infiltration of chronic inflammatory cells into the middle-to-deeper mucosal layer might be features of early AIG. In the future, it is necessary to accumulate similar cases and clarify the natural course of AIG.
Acknowledgements
We thank Dr. Hidenobu Watanabe for his advice regarding the pathological diagnosis of the patient’s disease.
Funding
This study was completed without any financial support from Government or non-Government agencies.
Compliance with ethical standards
Conflict of interest
Maiko Kishino, Kenshi Yao, Hiroshi Hashimoto, Hiroki Nitta, Rie Kure, Ayako Yamamoto, Kana Yamamoto, Kouichi Nonaka, Shinichi Nakamura, and Katsutoshi Tokushige declare that they have no conflict of interest.
Human rights
All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Kurokawa K, Maruyama M, Watanabe S, et al. Study of the gastric mucosal atrophic pattern and the complication of gastric cancer in pernicious anemia patients and their family members. Gastroenterol Endosc. 1981;23:66–77. [Google Scholar]
- 2.Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis. 1973;18:426–440. doi: 10.1007/BF01071995. [DOI] [PubMed] [Google Scholar]
- 3.Terao S, Suzuki S, Yaita H, et al. Multicenter study of autoimmune gastritis in Japan: clinical and endoscopic characteristics. Dig Endosc. 2020;32:364–372. doi: 10.1111/den.13500. [DOI] [PubMed] [Google Scholar]
- 4.Yao K, Iwashita A, Matsui T, et al. A new diagnostic classification system by magnification endoscopy and narrow-band imaging in the stomach: Microvascular (MV) architecture and microsurface (MS) structure. In: Niwa H, Tajiri H, Nakajima M, et al., editors. New challenges in gastrointestinal endoscopy. Tokyo: Springer; 2008. pp. 169–176. [Google Scholar]
- 5.Yagi K, Nakamura A, Sekine A, et al. Features of the atrophic corpus mucosa in three cases of autoimmune gastritis revealed by magnifying endoscopy. Case Rep Med. 2012;2012:368160. doi: 10.1155/2012/368160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Torbenson M, Abraham SC, Boitnott J, et al. Autoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands. Mod Pathol. 2002;15:102–109. doi: 10.1038/modpathol.3880499. [DOI] [PubMed] [Google Scholar]
- 7.Samloff IM, Varis K, Ihamaki T, et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982;83:204–209. doi: 10.1016/0016-5085(82)90176-7. [DOI] [PubMed] [Google Scholar]
- 8.Tozzoli R, Kodermaz G, Perosa AR, et al. Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev. 2010;10:80–83. doi: 10.1016/j.autrev.2010.08.006. [DOI] [PubMed] [Google Scholar]